Jodie Ouahed, MD, MMSc

Director, VEOIBD Clinic; Gastroenterologist, Inflammatory Bowel Disease Center
Assistant Professor, Harvard Medical School
Image
Jodie Ouahed, MD, MMSc

Jodie Ouahed, MD, MMSc

Director, VEOIBD Clinic; Gastroenterologist, Inflammatory Bowel Disease Center
Assistant Professor, Harvard Medical School
Education
Undergraduate School
McGill University
2003
Montreal
Canada
Medical School
University of McGill
2008
Montreal
Canada
Internship
McMaster Children’s Hospital
2011
Hamilton
Canada
Residency
McMaster Children’s Hospital
2011
Canada
Fellowship
Clinical - Pediatric Gastroenterology Hepatology and Nutrition
McMaster Children’s Hospital
2012
Boston
MA
US
Fellowship
Research, Snapper Laboratory
Boston Children's Hospital
2014
Boston
MA
US
Graduate School
Scholars in Clinical Sciences Program
Harvard Medical School
2014
Boston
MA
US
Fellowship
IBD
Boston Children's Hospital
2015
Boston
US
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Gastroenterology)
Professional History

Dr. Ouahed is a pediatric gastroenterologist involved in the clinical care of many complex patients with focus on those with Inflammatory Bowel Diseases (IBD) and immune dysregulations. Her area of expertise is in Inflammatory Bowel Disease (IBD). She attended McGill Medical School and completed her residency at McMaster Children’s Hospital in Canada. She went on to complete her fellowship in pediatric gastroenterology and nutrition, followed by an advanced fellowship in IBD at Boston Children's Hospital, where she now works as an attending physician. Dr. Ouahed is involved in several translational research projects focused on the genetics underlying early onset of IBD.

Dr. Ouahed serves as an expert for the Department of Gastroenterology for Boston Children's Hospital Precision Medicine Service. For more information about the Precision Medicine Service please visit bostonchildrens.org/precisionmed.

Publications

Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease. View Abstract
Breaking Down Barriers: Epithelial Contributors to Monogenic IBD Pathogenesis. View Abstract
Bacterial Sphingolipids Exacerbate Colitis by Inhibiting ILC3-derived IL-22 Production. View Abstract
Factors Associated With Chronic Intestinal Inflammation Resembling Inflammatory Bowel Disease in Pediatric Intestinal Failure: A Matched Case-Control Study. View Abstract
Understanding inborn errors of immunity: A lens into the pathophysiology of monogenic inflammatory bowel disease. View Abstract
Clinical Phenotypes and Outcomes in Monogenic Versus Non-monogenic Very Early Onset Inflammatory Bowel Disease. View Abstract
Mucus sialylation determines intestinal host-commensal homeostasis. View Abstract
Pediatric Gastrointestinal Histopathology in Patients With Tetratricopeptide Repeat Domain 7A (TTC7A) Germline Mutations: A Rare Condition Leading to Multiple Intestinal Atresias, Severe Combined Immunodeficiency, and Congenital Enteropathy. View Abstract
Variants in STXBP3 are Associated with Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation. View Abstract
Expanding Contributions of Monogenic Very Early Onset Inflammatory Bowel Disease. View Abstract
Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. View Abstract
Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review. View Abstract
Risk-factors Associated with Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review. View Abstract
Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis. View Abstract
An integrated clinical program and crowdsourcing strategy for genomic sequencing and Mendelian disease gene discovery. View Abstract
Molecular Comparison of Adult and Pediatric Ulcerative Colitis Indicates Broad Similarity of Molecular Pathways in Disease Tissue. View Abstract
Genetic and Structural Analysis of a SKIV2L Mutation Causing Tricho-hepato-enteric Syndrome. View Abstract
Fatal Central Nervous System Disease Following First Infliximab Infusion in a Child With Inflammatory Bowel Disease. View Abstract
Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3. View Abstract
The diagnostic approach to monogenic very early onset inflammatory bowel disease. View Abstract
Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. View Abstract
Role of wireless capsule endoscopy in reclassifying inflammatory bowel disease in children. View Abstract
Abdominal compartment syndrome secondary to chronic constipation. View Abstract
Case 2: Weight loss despite tube feeding. View Abstract
Cryptogenic organizing pneumonia after rituximab therapy for presumed post-kidney transplant lymphoproliferative disease. View Abstract
Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution. View Abstract